Dr. Bruce Walter Hoggan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 225 Callahan Ave., Parachute, CO 81635 Phone: 970-285-7748 Fax: 970-285-6824 |
News Archive
Rice University researchers have built a simulation to show how cancerous tumors manipulate blood-vessel growth for their own benefit.
Researchers have found a genetic flaw that may explain why some people get more ill with flu than others. The study was reported in the journal Nature this Sunday, where researchers said the variant of the IFITM3 gene was much more common in people hospitalized for flu than in the general population. It controls a malformed protein, which makes cells more susceptible to viral infection. Experts said those with the flaw could be given the flu jab, like other at-risk groups.
Researchers have found abnormal neural function in patients with primary insomnia, which may help explain why these patients find it hard to concentrate on daytime tasks despite the absence of objectively measured cognitive deficits.
In a randomized trial that included about 2,000 patients with or at high risk of cardiovascular disease (CVD), use of a fixed-dose combination medication for blood pressure, cholesterol, and platelet control compared to usual care resulted in significantly improved medication adherence after 15 months and small improvements in systolic blood pressure and low-density lipoprotein cholesterol, according to a study in the September 4 issue of JAMA.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
› Verified 8 days ago